| Bioactivity | HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV activity. HEP-1 enhances antibody titers generated by hepatitis B vaccination. HEP-1 has the potential to be studied against viral infections[1]. |
| Name | HEP-1 |
| CAS | 174641-44-2 |
| Sequence | Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu |
| Shortening | TEKKRRETVEREKE |
| Formula | C74H132N26O27 |
| Molar Mass | 1818.00 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Holms RD, et al. Ezrin Peptide Therapy from HIV to COVID: Inhibition of Inflammation and Amplification of Adaptive Anti-Viral Immunity. Int J Mol Sci. 2021 Oct 28;22(21):11688. |
HEP-1
CAS: 174641-44-2 F: C74H132N26O27 W: 1818.00
HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV activity. HEP-1 enhances antibody titers
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.